Enfortumab vedotin is one of the recent additions when it comes to new and latest FDA approved drugs. This is a more specific reference to cancer care medicines recommended for advanced conditions. The commercial identity of Enfortumab vedotin is Padcev, a brand available as 20mg and 30mg single dose vials. Enfortumab should be shipped in regulated temperature conditions, strictly enforced during the transit as well. This innovative drug is developed by Astellas Pharma.
Padcev 20mg & Padcev 30mg – Global regulatory approvals
Enfortumab FDA approval was first granted in 2019, which is relatively recent in the scenario of cancer care drugs. The indication was very specific for locally advanced or metastatic urothelial cancer. The approval was also specific to the patients who already underwent treatment with PD-1 or PD-L1 inhibitor along with platinum based chemo. EMA has very recently accepted the marketing authorization application for Padcev. At present, this drug is jointly promoted by Astellas and Seagen.
- In the management of advanced urotherlial cancer, Enfortumab is recommended based on the clinical data and regulatory approvals. It is classified as a monoclonal antibody drug which acts as an antibody drug conjugate. More data is likely to emerge based on the ongoing clinical research and the peer review publications.
- The dose of Padcev is determined based on the patient’s body weight and dose reduction schedule is applicable depending on the tolerability. The accelerated approval given in the US for this drug had considered the clinical data from 125 patients. Based on the outcomes, it was also given the breakthrough therapy designation.
Enfortumab India – Understanding access and legal methods of procurement
Enfortumab vedotin in India is one of the sort-after medications in the advanced settings of cancer care management. Not having enough alternatives to this drug makes it a more compelling reason to fast track its procurement. But, it is not as simple as someone getting to search for it online. The entire procedure could be more strenuous unless supported by experienced people.
Only searching online for Enfortumab price in India need not essentially take to the right source. The chances are high that the reliable sources that can actually help with procurement may not be found on search engines. It is always a better practice to check with the treating physicians for references regarding suppliers dealing with Enfortumab in India. Their prior experience will always be of help and assistance. Padcev price in India could change based on so many global factors, currency rates remain one of the most common factors to that effect.
Hassle free Sourcing of Enfortumab in India
As per the DGCI guidelines, patients can seek and procure legal permits from CDSCO. Its portal is very user friendly and is designed to help patients to procure legal access to drugs that are not available in India. Patient specific licenses for Enfortumab vedotin in India shall be considered upon the recommendation of an Oncologist. Patients can very well touch base with international suppliers and pay for official import of Padcev in India. The whole procedure for sourcing, procurement and shipment shall take one or two weeks. It depends on the availability of the drug as well as the efficiency of the supplier. It is always a good idea to plan everything in a way that all the necessary procedures are completed at once; they remain in effect for future supplies as well.
Contact Noel Biotech – +91 9677010046 / +91 992977766; firstname.lastname@example.org